LsBioPath, a Saratoga-based med-tech firm, develops real-time imaging products for breast cancer surgery, enhancing patient outcomes and cost-efficiency.
LsBioPath is a medical technology company focused on developing real-time imaging solutions for breast cancer surgery. Their flagship product, the ClearEdge imaging device, is a hand-held, battery-operated tool with a sterile single-use probe designed to provide immediate visualization of excised tissue margins during surgery. This technology aims to improve patient outcomes and reduce the need for follow-up procedures by ensuring tumor-free margins during initial breast-conserving surgeries.
Based in Saratoga, California, LsBioPath addresses a critical need in breast cancer treatment. By enabling surgeons to assess tissue margins in real-time, their technology has the potential to decrease local recurrence rates and reduce overall healthcare costs. The company's innovative approach to intraoperative imaging represents a significant advancement in breast cancer surgical techniques.
